Viewing Study NCT03008369


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-25 @ 8:40 PM
Study NCT ID: NCT03008369
Status: COMPLETED
Last Update Posted: 2024-02-20
First Post: 2016-12-28
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery
Sponsor: Mayo Clinic
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-05-31
Start Date Type: ACTUAL
Primary Completion Date: 2020-12-01
Primary Completion Date Type: ACTUAL
Completion Date: 2022-09-28
Completion Date Type: ACTUAL
First Submit Date: 2016-12-28
First Submit QC Date: None
Study First Post Date: 2017-01-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-07-01
Results First Submit QC Date: None
Results First Post Date: 2021-05-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-26
Last Update Post Date: 2024-02-20
Last Update Post Date Type: ACTUAL